Minipigs logo


Webinar presentations:

13 June 2019:
Minipigs in human relevant safety assessment - learnings from Roche (Safety Pharmacology & Toxicology/Pathology) by Susanne Mohr, Andrea Greiter-Wilke and Björn Jacobsen

2019 SOT Baltimore

We hosted two sessions with Marshall BioReseources, and the presentations are available upon request to Peter Vestbjerg at

The first session: “Using the Göttingen Minipigs - Why, When, How?” consisted of two talks:

  • Using the Göttingen Minipigs – Why, When, How?
    Simon Authier, DVM, MBA, PhD, DSP, Senior Director of Scientific Operations and Veterinary Science at Citoxlab North America


  • Göttingen Minipigs as non-rodent species – specific advantages
    Henrik Duelund Pedersen, DVM, DrVetSci, MIND, Affiliated Professor, CSO at Ellegaard Göttingen Minipigs A/S

The second session “Göttingen Minipigs in Dermal Studies” consisted also of two talks:

  • Development of the immune system associated with cutaneous tissues in the juvenile Göttingen Minipig
    Linda Allais, Director of Toxicology at Charles River Lyon SA, Safety Assessment, France


  • The use of Göttingen Minipigs in Dermal Studies
    Andy Makin, Scientific Director and Director of Business Development Europe at Citoxlab Denmark 

2018 SOT ToxExpo

We hosted two sessions with Marshall BioResources, and the presentations are available below. 

The first session: ”The CONFIRM Initiative: Immunological Safety Evaluation in Minipigs“ consisted of two talks:


The second session consisted of one talk: